NEW YORK (GenomeWeb News) – Genetic Technologies has filed four separate lawsuits claiming infringement of a patent covering its non-coding DNA technology.

Its case against Genesis Genetics Institute was filed in US District Court, Eastern District of Michigan, Southern Division on Sept. 13. In separate cases, it also sued Reprogenetics and Medical Diagnostic Laboratories in the US District Court for the District of New Jersey on Sept. 26, and it sued IVF Institute in the US District Court for the District of Eastern Virginia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.